Effect of AF, olaparib and aurola treatment on immune-related

$ 27.50

4.9
(590)
In stock
Description

Immunotherapeutic approaches for small-cell lung cancer

PDF) Auranofin Synergizes with the PARP Inhibitor Olaparib to

Evelien SMITS, Full Professor, PhD

Frontiers The potential of PARP inhibitors in targeted cancer therapy and immunotherapy

Inhibition of poly(ADP-ribosyl)ation in cancer: Old and new paradigms revisited - ScienceDirect

PDF) Auranofin Synergizes with the PARP Inhibitor Olaparib to

Effect of AF, olaparib and aurola treatment on immune-related

beta Actin Polyclonal Antibody (20536-1-AP)

Jinthe VAN LOENHOUT, PhD Student

Interface between obesity with dysfunctional metabolism and inflammation, and the triple-negative breast cancer in African American women

The intracellular gold concentration levels caused by the

Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside review - ScienceDirect

Antitumor effect of a WEE1 inhibitor and potentiation of olaparib sensitivity by DNA damage response modulation in triple-negative breast cancer

Lived experiences of women reporting fatigue during PARP inhibitor maintenance treatment for advanced ovarian cancer: A qualitative study - Gynecologic Oncology